$AEON Cashflow Statement | Understand Stock

$AEON

$0.24 +$0.00 (0.04%) Close

$AEON Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 5 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Interest earned on investments held in Trust Account
Depreciation
Write-off of deferred offering costs
Stock-based compensation expense
Non-cash issuance of common stock
Write-off of acquired in-process research and development
Change in fair value of convertible notes
Change in fair value of warrants
Gain on forgiveness of deferred underwriting fee payable
Offering costs allocated to warrant liabilities
Change in fair value of embedded forward purchase agreements and derivative liabilities
Change in fair value of embedded forward purchase agreements
Loss on derivative liability
Change in fair value of contingent consideration
Other
Changes in operating assets and liabilities:
Prepaid assets
Franchise tax payable
Deferred tax liability
Accrued expenses
Prepaid expenses and other current assets
Accounts payable
Accrued expenses and other liabilities
Other assets and liabilities
Net cash used in operating activities

Cash flows from investing activities:
Principal invested into Trust account
Withdraw from Trust Account
Purchases of property and equipment
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from issuance of convertible notes
Repayment of convertible notes
Offering costs
Proceeds from issuance of Private Placement Warrants
Proceeds from working capital loans
Borrowing from promissory note
Repayment of promissory note
Proceeds from issuance of public offering shares, net
Public Offering
Total proceeds from issuance of public offering shares, net

Net cash provided by financing activities
Net decrease in cash

Cash and cash equivalent at beginning of period
Predecessor
Successor
Total cash and cash equivalent at beginning of period
Cash and cash equivalent at end of period
Predecessor
Successor
Total cash and cash equivalent at end of period

Deferred underwriters' discount payable
Conversion of Working Capital Loans to Private Placement Warrants
Accretion of redeemable common stock
Supplemental disclosure of cash flow information:
Non-cash operating activities
Settlement of liability with common shares
Non-cash financing activities:
Cashless warrant exercises

Comments